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A number of studies indicate that the transmembrane domain, the cytoplasmic domain, or both regions of viral surface
glycoproteins are involved in quaternary structure formation. In this report, the transmembrane domain and cytoplasmic tail
coding sequence of the fusion (F) glycoprotein gene from parainfluenza type 2 virus was truncated by PCR and the resulting
gene (PI2F9) was expressed in HeLa-T4 cells by using the vaccinia virus-T7 transient expression system. Pulse–chase
experiments indicated that the anchor-free PI2F9 was expressed and processed into F1 and F2 subunits. Both the processed
and the unprocessed anchor-free PI2F9 proteins were found to be efficiently secreted into the culture medium. Examination
of the oligomeric form of the anchor-free PI2F9 by chemical cross-linking demonstrated that it assembles posttranslationally
into dimers and trimers with a pattern similar to that of the wild-type PI2F protein. In an effort to better understand the
biological properties of the truncated form of PI2F9, we anchored PI2F9 by a glycosyl-phosphatidylinositol (GPI) linkage. The
GPI-anchored PI2F9 protein, when coexpressed with PI2HN, did not induce cell fusion seen as syncytium formation, but was
found to initiate lipid mixing (hemifusion) as observed by transfer of R-18 rhodamine from red blood cells to the GPI-PI2F9/
PI2HN cotransfected cells. The results therefore indicate that the extracellular domain of the PI2 fusion protein contains not
only the structural information sufficient to direct assembly into higher oligomers, but also is competent to initiate membrane
fusion, suggesting that the anchor-free PI2F9 may be useful for further structural studies. © 2000 Academic Press
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Human parainfluenza viruses are negative-strand en-
veloped RNA viruses that belong to the family Paramyxo-
viridae (Lamb and Kolakofsky, 1996). They are important
respiratory tract pathogens of infants and young chil-
dren. Infection by paramyxoviruses proceeds by fusion of
the viral envelope and cellular membrane, with entry of
only the nucleocapsid into the cytoplasm of the cell. It is
well known that the entry of enveloped viruses is deter-
mined by an interaction between specific receptors on
the target cell surface and envelope glycoproteins on the
virion. The parainfluenza viruses encode two envelope
glycoproteins, the hemagglutinin-neuraminidase protein
(HN) and fusion protein (F). The HN protein is a type II
integral membrane protein with an amino-terminus lo-
cated inside the virus and a carboxy-terminal ectodo-
main. The ectodomain binds to sialic acid residues that
serve as viral receptors on the target cells. The F protein
is a type I integral membrane protein that has a large
ectodomain containing a cleavable signal sequence at
the N-terminus, a hydrophobic transmembrane domain,
and a short cytoplasmic tail. The F protein monomer is
synthesized as an inactive larger Fo precursor molecule
and is cleaved posttranslationally into the biologically
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368active forms by a trypsin-like host endoprotease as ob-
served for Sendai virus or by intracellular furin as ob-
served for most other paramyxoviruses (Lamb and Kola-
kofsky, 1996). This results in the production of F1 and F2
subunits that are covalently linked by disulfide bridges
(Homma and Ohuchi, 1973; Scheid and Choppin, 1974).
The native F protein exists as homo-oligomeric trimers,
which have been observed in cross-linking studies (Rus-
sell et al., 1994). The cleavage of the Fo protein exposes
a new hydrophobic domain designated the fusion pep-
tide at the N-terminus of the F1 subunit, which is believed
o participate directly in the fusion process (Lamb, 1993).
The mechanism of paramyxovirus-induced membrane
usion has not been well defined. Previous studies in our
aboratory showed that cell fusion caused by human
arainfluenza virus type 2 and type 3 glycoproteins re-
uires coexpression of F and HN proteins from the same
irus type (Hu et al., 1992; Yao and Compans, 1995).
ther reports have shown similar type-specific interac-
ions among paramyxovirus envelope glycoproteins
Horvath et al., 1992; Cattaneo and Rose, 1993; Malvoisin
and Wild, 1993; Bousse et al., 1994; Heminway et al.,
994; Wild et al., 1994). It has been proposed that the HN
nd F proteins must communicate in a virus-specific
anner, allowing a functional molecular interaction be-
ween homotypic HN and F proteins (Lamb, 1993). Stud-
es with chimeric proteins have provided evidence that
pecific regions on F and HN proteins that are involved
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369PI2 FUSION PROTEINin this type-specific interaction reside in the extracellular
domain (Sergel et al., 1993b; Tanabayashi and Compans,
1996).
It was previously observed that a cytoplasmic tail
truncation mutant of the PI2F protein was similar to the
wild-type (wt) PI2F protein with reference to biosynthe-
sis, oligomerization, intracellular transport, fusogenic ac-
tivity, and virus type-specific F and HN interaction (Yao
and Compans, 1995). In this study, we have constructed
a cytoplasmic tail- and transmembrane domain-trun-
cated F protein mutant of parainfluenza type 2 virus
(PI2F9) and compared its expression, processing, and
oligomerization with that of the wild-type PI2F protein.
We also constructed a GPI-anchored PI2F9 molecule and
investigated the role of the ectodomain in the promotion
of cell fusion.
RESULTS AND DISCUSSION
Construction and expression of soluble PI2F9 and
GPI-anchored PI2F9
A segment of the PI2F cDNA in pGEM 3 (pGEM-3-
PI2F) was used as template for oligonucleotide-directed
mutagenesis by PCR to introduce a premature stop
codon into the coding sequence as shown in Fig. 1. The
resulting PCR product no longer contained the nucleo-
tide sequence encoding the transmembrane domain and
the cytoplasmic tail. The soluble PI2F9 protein was ex-
pressed by using the vaccinia virus-bacteriophage T7
RNA polymerase transient expression system (Fuerst et
al., 1986) and compared to wild-type PI2F protein. As
shown in Fig. 2, in the cell lysate, the anchor-free PI2F9
mutant protein (lane 2) was expressed at a level compa-
rable to that of the wild-type PI2F (lane 1) and both the Fo
precursor and the F1 cleavage products were detected,
although lower levels of the processed F1 cleavage prod-
uct were observed with the anchor-free PI2F9. The un-
processed anchor-free PI2F9 protein showed the ex-
pected decrease in molecular mass (estimated molecu-
FIG. 1. Schematic structure of PI2F, PI2F9, and PI2F9-GPI. The PI2F
ransmembrane domain is indicated as a shaded box. The GPI anchor
s shown as a cross-hatched box. The number on the right indicates the
ize (in amino acids) of the wild-type PI2F. The arrow and the number
n the top indicate the site where the premature stop codons were
ntroduced.lar mass of 54 kDa), compared with that of the wild-type
cPI2F (estimated molecular mass of 60 kDa). The effi-
ciency of proteolytic processing may be affected by the
lack of anchoring to the membrane, resulting in a de-
creased level of the processed F1 cleavage product. As
xpected, the anchor-free PI2F9 proteins were found to
e efficiently secreted into the medium while the wild-
ype anchored PI2F proteins were primarily distributed
n the cell surface.
To study the biological properties of the soluble PI2F9,
he coding sequence for a chimeric GPI-PI2F9 was con-
tructed by overlapping PCR as described under Mate-
ials and Methods. We substituted the transmembrane
nd cytoplasmic tail domains of PI2F with a 45-aa pep-
ide of carboxy-terminal amino acids of CD16B. This
mall peptide constitutes a signal for GPI anchor addi-
ion (Low, 1989; Scallon et al., 1989; McHugh et al., 1995).
uring translocation into the endoplasmic reticulum, this
eptide is cleaved and the GPI tail is added. The GPI-
nchored PI2F9 was transfected into HeLa-T4 cells and
xpressed by the VV-T7 transient expression system. As
hown in Fig. 2, the GPI-anchored PI2F9 (lane 3) was
xpressed and both the F0 precursor and the F1 cleavage
products were detected. To address whether the GPI-
anchored PI2F9 protein was expressed at the cell sur-
face, cells expressing the GPI-anchored PI2F9 protein
were radiolabeled with [35S]methionine/cysteine and the
roteins on cell surface were identified with a mem-
rane-impermeable biotinylation reagent. As shown in
ig. 2, the GPI-anchored PI2F9 protein was found to be
ransported to the cell surface, although somewhat lower
evels of the GPI-anchored PI2F9 protein were found both
n the cell lysates and on the cell surface as compared to
hose of wt 2F. These results indicated that GPI-an-
hored PI2F9 is expressed, processed in HeLa-T4 cells,
nd efficiently transported to the cell surface, as also
FIG. 2. Expression of the anchor-free PI2F9 (lane 2), wild-type PI2F
(lane 1), and GPI-PI2F9 (lane 3) proteins expressed in HeLa-T4 cells
using the vTF7-3 transient expression system. At 8 h postransfection,
cells were pulse-labeled with 100 mCi of [35S]methionine/cysteine for
0 min at 37°C and chased with nonradioactive chase medium (DMEM
ontaining 10% fetal calf serum) for a 2-h chase period. After being
abeled, cells were biotinylated and lysed, and the chase medium were
ollected. The cell lysates (on the left) and the chase medium (on the
ight) were immunoprecipitated with rabbit or guinea pig anti-PI2 anti-
erum and protein A–agarose beads. The PI2-specific proteins on the
ell surfaces (in the middle) were detected as described under Mate-
ials and Methods. Proteins were analyzed by SDS–8% PAGE under
educing conditions. The bands below both the wt 2F1 and GPI-an-
hored 2F91 in the cell lysate were not observed using other PI2
antisera and are therefore thought to be nonspecific.
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370 TONG AND COMPANSreported for other chimeric molecules containing GPI
anchors in place of their normal transmembrane do-
mains (Crise et al., 1989; Lin et al., 1990; Singh et al.,
1990; Duval et al., 1992; Gilbert et al., 1993; Weiss and
White, 1993; Zhou et al., 1997).
Kinetics of secretion of soluble PI2F9
To determine the kinetics by which the anchor-free
PI2F9 protein was transported through the secretory
pathway, a time course analysis was performed. As de-
picted in Fig. 3, the PI2F9 protein is discernible in the
culture supernatant as early as 30 min after chases. As
the time of chase was increased, the level of the se-
creted PI2F9 increased and it was found to accumulate in
the medium, whereas the level of PI2F9 detected in cell
lysate was correspondingly reduced. We found that at
180 min about 80% of the soluble PI2F remained in cell
lysates, while about 50% of the wt PI2F remained in cell
lysates (Fig. 4). This indicates that the kinetics of secre-
tion for the anchor-free PI2F9 protein mutant were slower
than those for the transport of wt PI2F protein to the cell
surface as shown in Fig. 4. This result is consistent with
previous results showing that transport from the ER to
the Golgi and from the Golgi to the plasma membrane is
slower for anchor-free molecules than for membrane-
anchored molecules (Copeland et al., 1986; Singh et al.,
1990).
Analysis of the oligomeric state of the PI2F9 protein
Previous mutational studies have shown that proper
assembly of envelope glycoproteins is necessary for
their biological functions (Gething et al., 1986; Kreis and
Lodish, 1986; Thompson et al., 1988; Parks and Lamb,
1990a; Takimoto et al., 1992; Doms et al., 1993). The
paramyxovirus fusion protein is directly involved in the
process of fusion of the viral envelope and cell mem-
FIG. 3. Kinetics of secretion of the anchor-free PI2F9 protein into the
medium. HeLa-T4 cells expressing the anchor-free PI2F9 protein were
abeled with 100 mCi of [35S]methionine/cysteine at 37°C at 8 h post-
transfection for 30 min and incubated in chase medium (DMEM con-
taining 10% fetal calf serum) for 30-, 60-, 180-, or 300-min chase periods.
The cells were lysed and the culture supernatants were also collected
at the indicated time point. PI2F9 polypeptides were immunoprecipi-
tated with PI2-hyperimmune rabbit serum and analyzed by SDS–PAGE
on an 8% gel under reducing conditions.brane. A trimeric envelope glycoprotein structure has
p
ipreviously been proposed for the wild-type PI2F protein
and other paramyxovirus fusion proteins that were ana-
lyzed via cross-linking chemically (Walsh et al., 1985;
Sechoy et al., 1987; Arumugham et al., 1989; Collins and
Mottet, 1991; Anderson et al., 1992; Russell et al., 1994;
Yao and Compans, 1995; Tong and Compans, 1999). To
investigate the assembly of the soluble form and GPI-
anchored form of PI2F9 in comparison with the wt PI2F
glycoprotein, we compared the pattern of oligomer for-
mation of the proteins after cross-linking with the reagent
3,3-dithiobis(sulfosuccinimidyl propionate (DTSSP). As
shown in Fig. 5, after cross-linking the soluble form and
GPI-anchored form of the PI2F9 proteins with DTSSP in
NP-40-solubilized cell extracts, we consistently observed
three prominent PI2F9 and GPI-anchored 2F9 protein
bands migrating at the positions of homotrimers, ho-
modimers, and monomers. No additional larger bands
were detected even in the presence of a high concen-
tration of DTSSP. In this respect, the soluble form of the
PI2F9 proteins did not show any significant difference
from the wt PI2F protein in PI2 virus-infected or PI2F-
transfected cells (Yao and Compans, 1995). These re-
sults indicate that the transmembrane domain and cyto-
plasmic domain of the PI2F protein are not essential for
the formation of the PI2F homotrimers. Previous studies
have shown that some cytoplasmic domain mutants,
transmembrane domain mutants, or transmembrane and
cytoplasmic domain truncation mutants were unable to
assemble into oligomeric forms (Rose and Bergmann,
1983; Doms and Helenius, 1988; Rose and Doms, 1988;
Parks and Lamb, 1990b; Singh et al., 1990; Sergel et al.,
1993a; Sergel and Morrison, 1995; Yao and Compans,
1995; Center et al., 1997). We believe that this is the first
report of oligomer formation solely between ectodomain
subunits of paramyxovirus fusion proteins. It indicates
that oligomerization of the PI2F protein might have less
stringent structural requirements and that structural fea-
tures sufficient for oligomerization of the protein must
reside in the extracellular domain. As expected, the GPI-
FIG. 4. Kinetics of cell surface transport of the wt PI2F. HeLa-T4 cells
expressing the anchor-free PI2F protein were labeled with 100 mCi of
35S]methionine/cysteine at 37°C at 8 h posttransfection for 30 min and
ncubated in chase medium (DMEM containing 10% fetal calf serum) for
0-, 60-, 180-, or 300-min chase periods. The cells were lysed and PI2F
olypeptides were immunoprecipitated with PI2-hyperimmune guinea
ig serum. The cell surface wt 2F proteins were detected via biotiny-
ation analysis as described under Materials and Methods. The PI2F
olypeptides were analyzed by SDS–PAGE on an 8% gel under reduc-
ng conditions.
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371PI2 FUSION PROTEINanchored form of 2F9 was able to be normally oligomer-
zed as was also reported for other GPI-anchored viral
nvelope proteins (Singh et al., 1990; Gilbert et al., 1993;
Weiss and White, 1993).
To determine the rate of oligomerization of the anchor-
free PI2F9 protein in comparison to wt PI2F protein,
HeLa-T4 cells expressing the truncated and wt PI2F at
8 h posttransfection were pulse-labeled for 3 min with
100 mCi/ml of Trans [35S]methionine/cysteine and then
hased with an excess of nonradioactive chase medium
or 3-, 5-, 7-, 10-, or 15-min periods. Cell extracts were
ross-linked using a protocol described by Paterson and
amb (1993). PI2F and PI2F9 molecules were then immu-
oprecipitated and analyzed by nonreducing low-per-
entage SDS–PAGE and autoradiography. As shown in
ig. 6, within the 3-min pulse some of the labeled anchor-
ree PI2F9 was already found to form cross-linked oli-
omers (dimers and trimers). The maximum extent of
ross-linking into trimers was attained after approxi-
ately 10 min of chase. Similar results were obtained
ith the wt PI2F protein. These data establish that wt
I2F is assembled into trimers within a few minutes of
ompletion of synthesis of the polypeptide chain, and
runcation of the cytoplasmic tail and transmembrane
FIG. 5. Chemical cross-linking of wild-type PI2F, anchor-free PI2F9,
and GPI-anchored 2F9 proteins. HeLa-T4 cells were infected with
vTF7-3 at a m.o.i. of 10 for 1 h at 37°C and then transfected with
wild-type PI2F (lane A), GPI-anchored PI2F9 (lane B) or anchor-free
PI2F9 clones (lane C). At 8 h posttransfection, transfected cells were
labeled with 100 mCi of [35S]methionine/cysteine for 60 min at 37°C.
fter chasing in nonradioactive chase medium for 2 h, cross-linking
eagent (1 mM DTSSP) was added to 0.5% NP-40-solubilized cells for
0 min at 4°C and then free DTSSP was quenched with 50 mM glycine
or 5 min at 4°C. Immunoprecipitations were performed after the cross-
inking reaction. Proteins were analyzed by 3.5% SDS–PAGE gel under
onreducing conditions. 1, 2, and 3 represent monomer, dimer, and
rimer, respectively. The positions of protein size markers are shown on
he left.omain did not significantly alter the rate of oligomerormation, although the initial rate of soluble form 2F9
ligomerization was seen to be slower.
embrane fusion activity of the GPI-anchored PI2F9
The cell fusion process involves several steps includ-
ng the formation of a membrane stalk, mixing of both the
uter membrane leaflet lipids normally called hemifu-
ion, and pore formation or mixing of inner leaflet mem-
rane lipids with concomitant mixing of the aqueous
ontents of donor and target cells (Hernandez et al.,
996). Since the soluble form of PI2F9 that we con-
tructed was capable of forming a homotrimer, we inves-
igated whether the cytoplasmic tail- and transmem-
rane domain-truncated PI2F9 protein still remained bi-
logically active. We constructed GPI-anchored PI2F9,
hich has shown cell surface expression and biologi-
ally active trimer formation, and we compared its fuso-
enic activity with that of the wt F protein. Coexpression
f the GPI-PI2F9 with homotypic HN was not observed to
FIG. 6. Time course of oligomer formation of wild-type PI2F and
anchor-free PI2F9 proteins. At 8 h posttransfection, HeLa-T4 cells ex-
pressing wild-type PI2F or anchor-free PI2F9 proteins were labeled with
100 mCi of [35S]methionine/cysteine for 3 min at 37°C and then chased
in nonradioactive chase medium (DMEM containing 10% fetal calf
serum) for 3-, 5-, 7-, 10-, or 15-min chase periods. The labeled HeLa-T4
cells then were cross-linked as described for Fig. 5. PI2F and PI2F9
molecules were immunoprecipitated and analyzed by nonreducing
3.5% SDS–PAGE gel and autoradiography. The positions of protein size
markers are shown on the left.
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372 TONG AND COMPANScause cell fusion as judged by syncytium formation (data
not shown) and by a content mixing assay (shown in Fig.
7). We employed the octadecyl rhodamine B (R18) assay
to measure whether GPI-PI2F9 mediates lipid mixing of
the outer leaflet membrane. The lipophilic probe R18 was
incorporated into guinea pig red blood cells (RBCs),
which were then mixed with HeLa-T4 cells that ex-
pressed various combinations of viral membrane glyco-
proteins. When cells coexpressing the wt PI2F or GPI-
anchored PI2F9 protein with the homotypic HN proteins
were mixed with R18-labeled erythrocytes, transfer of
fluorescence from the RBCs to the expressing cells was
detected as shown in Fig. 8. However, when HeLa-T4
cells coexpressing the homotypic HN protein with an-
chor-free PI2F9 or expressing the homotypic HN alone
were incubated with R18-labeled RBCs, no transfer of
fluorescence from the RBCs to the expressing cells was
detected. Thus, we found that the GPI-anchored PI2F9
mediated the transfer of the lipophilic fluorescent probe
R18 from R18-labeled erythrocyte membranes to ex-
pressing cells, but failed to mediate complete fusion
seen as syncytium formation. These results indicate that
the ectodomain of PI2F is able to mediate hemifusion. It
has been demonstrated that after the fusion peptide
inserts into a target cell membrane, the protein forms a
hairpin structure that draws the two membranes into
close proximity, thereby facilitating their union, hemifu-
sion, and complete fusion (Weissenhorn et al., 1997;
Montefiori and Moore, 1999; Lamb et al., 1999). In
paramyxoviruses, a conformational change of the fusion
protein during the fusion process has been suggested
(Lamb, 1993). Our results suggest that a GPI anchor
penetrating through only the outer leaflet is sufficient for
PI2F9 to promote hemifusion while a transmembrane
domain is required for PI2F to form a stable fusion pore
that can subsequently dilate, leading to complete fusion.
From these experiments we can conclude that the
ectodomain remains biologically active in the absence of
the transmembrane and cytoplasmic domains. A similar
study of GPI-anchored influenza hemagglutinin has
shown promotion of hemifusion, but not complete fusion
(Kemble et al., 1994).
In summary, a soluble form of the extracellular domain
of PI2F is stably expressed in HeLa-T4 cells. Character-
ization of this anchor-free PI2F9 glycoprotein demon-
strated that it was efficiently secreted and was folded
spontaneously into oligomers. The observation of three
prominent cross-linked bands on sodium dodecyl sul-
fate–polyacrylamide gel electrophoresis (SDS–PAGE)
that closely resemble those found with wt PI2F indicated
that the ectodomain of PI2F9 protein preserves its native
rimeric structure. Additionally the GPI-anchored PI2F9
lycoprotein was found to mediate lipid mixing, suggest-
ng that the GPI-anchored PI2F9 is biologically active.
tudies of the structure of the water-soluble ectodomain
f influenza virus hemagglutinin (HA) have established a waradigm for virus glycoprotein-mediated membrane fu-
ion. Similarly, expression of a soluble F domain, devoid
f the cytoplasmic domain and transmembrane domain,
hould facilitate studies of the structure of the fusion
rotein of paramyxoviruses.
MATERIALS AND METHODS
ells, viruses, and plasmids
Monolayer cultures of HeLa-T4 cells and CV-1 cells
ere maintained in Dulbecco’s modified Eagle’s minimal
ssential medium (DMEM) supplemented with 10% fetal
alf serum (HyClone Laboratories, Inc., Logan, UT). The
ecombinant vaccinia virus vTF7-3 and wild-type vaccinia
irus strain IHD-J were kindly provided by Bernard Moss
National Institutes of Health, Bethesda, MD). Both vac-
inia virus stocks were propagated and titrated on CV-1
ells. All recombinant bacterial plasmids were propa-
ated in an Escherichia coli DH5a strain. The plasmid
GEM-3-PI2F encoded the PI2F fusion protein and was
escribed previously (Hu et al., 1990). The plasmid
CDM8-CD16B containing a DNA fragment encoding the
ignal for GPI-anchor attachment of CD16B (McHugh et
l., 1995) was a gift from Periasamy Selvaraj (Emory
niversity, Atlanta, GA).
onstruction of DNAs encoding soluble and
PI-anchored PI2F9 proteins
To PCR amplify a soluble PI2F9 coding sequence from
lasmid pGEM-3-PI2F, two synthetic oligonucleotides
ere used. The sense primer was the T7 primer, located
pstream of the PI2F coding sequence. The antisense
rimer corresponded to the 39-terminal 24 nucleotides of
he coding sequence for the PI2F ectodomain and car-
ied a stop codon and an EcoRI site. The resulting PCR
roduct encoding the entire ectodomain was digested
ith SalI and EcoRI and then ligated into vector pGEM-3,
hich was digested with SalI and EcoRI.
The GPI-anchored PI2F9 was constructed by the over-
apping PCR technique described by Ho et al. (1989) and
orton et al. (1989). The ectodomain sequence was PCR
mplified from the PI2F clone. The signal sequence for
PI-anchor attachment was PCR amplified from the
D16B clone. The antisense primer for the PI2F ectodo-
ain fragment contained a 12-nucleotide overhang at the
9 end complementary to the 59 end of the sense primer
or the signal sequence for GPI-anchor attachment. The
wo amplified gene sequences were annealed to each
ther and were further extended to generate the chimeric
PI-anchored PI2F9 by five cycles of PCR. Finally, the
himeric GPI-anchored PI2F9 was used as template and
mplified by PCR using two outer primers. The resulting
himera flanked with SalI/EcoRI sites was cloned into
ector pGEM-3 at the SalI/EcoRI sites. All end products
ere sequenced to confirm that the correct sequence
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from RBCs to cells was visualized and photographed with a Nikon fluo-
rescence microscope using a “fluorescein” filter set.
373PI2 FUSION PROTEINhad been obtained in the PCRs. A schematic diagram of
the constructs is shown in Fig. 1.
Transfection, radiolabeling, and immunoprecipitation
The mutant and the wild-type PI2F proteins were ex-
pressed by using the vaccinia virus-bacteriophage T7
RNA polymerase transient expression system (Fuerst et
al., 1986). Briefly, 35-mm dishes of subconfluent cells
were infected for 1 h with vTF7-3 at an m.o.i. of 10 and
then transfected with 5 mg plasmid DNA mixed with 10 ml
f Lipofectin (Gibco BRL, Gaithersburg, MD) in 1 ml of
MEM. At 8 or 16 h posttransfection, the transfected
ells were starved in DMEM lacking methionine and
ysteine for 30 min, pulse-labeled with 100 mCi/ml of
35S]methionine/cysteine for 30 min at 37°C, and then
hased with nonradioactive chase medium (DMEM con-
aining 10% fetal calf serum) for 30-, 60-, 180-, or 300-min
hase periods. The cells were washed and then lysed
ith cell dissociation buffer [10 mM Tris–HCl (pH 8.0),
50 mM NaCl, 0.5% Triton X-100, and 0.5% sodium de-
xycholate] at the indicated time point. The culture su-
ernatants, containing proteins that were secreted dur-
ng the expression period, were also collected. The cul-
ure supernatants and the cell lysate were analyzed for
nchor-free PI2F9 expression by incubation with PI2-
yperimmune rabbit or guinea pig serum for 2 or more h
t 4°C followed by precipitation with protein A–agarose
Immunopure; Pierce Chemical Co., Rockford, IL) for 2 h.
roteins were characterized by SDS–8% PAGE and by
ubsequent autoradiography. Each band of interest was
uantified by densitometry analysis using the National
nstitutes of Health image program.
ell surface biotinylation assay
Cell surface protein expression was detected by a
iotinylation assay as described by Le Bivic et al. (1989).
ight hours posttransfection, cells expressing GPI-an-
hored PI2F9 or wt PI2F proteins were starved in DMEM
acking methionine and cysteine for 1 h and pulse-la-
eled with 100 mCi/ml of [35S]methionine/cysteine for 30
min at 37°C. After chasing with DMEM containing 10%
fetal calf serum for the indicated period, cells were
washed three times with ice-cold PBS containing 0.1 mM
CaCl2 and 1 mM MgCl2 (PBS-CM) and incubated with 1
FIG. 8. Hemifusion of R18-labeled RBCs with HeLa-T4 cells express-
ing wild-type PI2F/PI2HN or GPI-PI2F9/PI2HN. Guinea pig RBCs were
labeled with the lipid probe R18 using a protocol described by Bagai
and Lamb(1995). At 16 h posttransfection, the R18-labeled RBCs were
overlaid onto HeLa-T4 cell monolayers expressing (a) PI2F/PI2HN, (b)
GPI-PI2F9/PI2HN, (c) PI2HN alone, or (d) anchor-free PI2F9/PI2HN and
first incubated at 4°C for 30 min and then incubated at 37°C for 60 min.
After incubation, R18 transfer from RBCs to cells was visualized andFIG. 7. Content mixing of calcein-labeled RBCs with HeLa-T4 cells
expressing wild-type PI2F/PI2HN or GPI-PI2F9/PI2HN. At 16 h posttrans-
fection at 32°C, the calcein-labeled RBCs were overlaid onto HeLa-T4 cell
monolayers expressing (a) PI2F/PI2HN, (b) GPI-PI2F9/PI2HN, (c) PI2HN
alone, or (d) anchor-free PI2F9/PI2HN and first incubated at 4°C for 30 min
and then incubated at 37°C for 60 min. After incubation, calcein transferphotographed with a Nikon fluorescence microscope using a “rhoda-
mine” filter set.
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374 TONG AND COMPANSml of a 0.5 mg/ml solution of sulfosuccinimidyl-2-(biotin-
amido)ethyl-1,3-dithiopropionate (NHS-SS-biotin; Pierce)
in PBS-CM at 4°C for 30 min. Free biotin was removed by
addition of DMEM and three washes with PBS-CM. Bio-
tinylated cell surface PI2F-specific proteins were identi-
fied by immunoprecipitation with PI2-specific antisera
and protein A–agarose beads (Pierce). Cell lysate beads
were washed three times and divided into two aliquots.
One aliquot was used for immunoprecipitation. The other
aliquot was boiled in 10 ml of 10% SDS and diluted with
.5 ml of lysis buffer. The supernatant from the protein
–agarose beads was incubated with streptavidin–aga-
ose beads and proteins were characterized by SDS–8%
AGE and autoradiography.
hemical cross-linking
Chemical cross-linking analysis was performed as de-
cribed previously (Russell et al., 1994) using the cross-
inking reagent DTSSP (Pierce Chemical Co.). In brief,
ubconfluent monolayers of HeLa-T4 cells in 35-mm-
iameter dishes were infected with recombinant vac-
inia virus vTF7-3 at an m.o.i. of 10. After 1 h of incubation
t 37°C, cells were transfected with 5 mg of plasmid DNA
and 10 ml of Lipofectin (Gibco BRL Life Technologies) in
1 ml of DMEM. At 8 h posttransfection, cells were starved
in DMEM lacking methionine and cysteine for 1 h, pulse-
labeled with 100 mCi/ml [35S]methionine/cysteine for the
ndicated time at 37°C, and then chased with DMEM
ontaining 10% fetal calf serum for the indicated period.
he radiolabeled cells were detached from the dish with
mM EDTA in PBS, washed, and resuspended in 100 ml
of PBS deficient in Mg21 and Ca21 (PBS2). The cells
were solubilized in 0.5% Nonidet-P40, treated with 2 mM
DTSSP at 4°C for 60 min, and inactivated with 50 mM
glycine for 5 min at 4°C. Immunoprecipitations were
performed as described above and the precipitates were
analyzed by SDS–3.5% PAGE under nonreducing condi-
tions.
Fusion of R18-labeled RBCs with cells expressing
GPI-anchored PI2F9
Guinea pig erythrocytes were labeled with the hydro-
phobic fluorescent dye R18 (Molecular Probes, Eugene,
OR) based on the procedure described previously (Bagai
and Lamb, 1995). Fifteen microliters of 1 mg/ml R18 in
ethanol was added to 10 ml of 1% fresh guinea pig
erythrocyte suspension in PBS while vortexing. After in-
cubation at room temperature in the dark for 30 min, 30
ml of DMEM with 10% fetal calf serum was added to the
suspension and further incubated for 20 min in order to
absorb the unbound probe. After labeling, the RBC sus-
pension was washed five times with 40 ml of PBS to
remove the unincorporated R18. The last washing step
was in PBS with the addition of 1 mM CaCl and 1 mM2
gCl2 (PBS11). The R18-labeled RBCs could be storedn PBS11 at 4°C for up to 24 h before use. To determine
embrane fusion, monolayer HeLa-T4 cells expressing
I2F/PI2 HN, GPI-anchored PI2F9/PI2 HN, PI2 HN, or
oluble PI2F9/PI2 HN at 16 h posttransfection at 32°C
ere washed twice with DMEM and then incubated for
h at 37°C with 50 mU per milliliter of neuraminidase in
MEM. The neuraminidase-treated cells were washed
wice with PBS and first incubated with 1 ml of R18-
abeled RBCs (0.2% hematocrit) in PBS11 at 4°C for 30
in in the dark with intermittent gentle agitation and then
ncubated at 37°C for 1 h. Unbound RBCs were removed
y two washes with PBS. Fusion was monitored and
hotographed by using an inverted fluorescence micro-
cope.
usion of calcein-labeled RBCs with cells expressing
PI-anchored PI2F9
Calcein AM (Molecular Probes, Leiden, The Nether-
ands) dissolved in dimethylsulfoxide was added to a 1%
rythrocyte suspension at a final concentration of 5 mM,
mmediately mixed, and incubated at room temperature
or 30 min in the dark. After incubation, 30 ml of DMEM
ith 10% fetal calf serum was added to the suspension
nd further incubated for 20 min in order to absorb the
nbound probe. Calcein-filled erythrocytes were washed
ive to six times and resuspended in PBS. Cell–erythro-
yte fusion was performed as described for the experi-
ents with R18-labeled erythrocytes. Permeation of cal-
ein from calcein-labeled RBCs to PI2F/HN, GPI-2F9/
HN, PI2F9/2HN or PI2HN expressing HeLa-T4 cells was
onitored by fluorescence microscopy and photograph-
cally recorded.
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